Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21603980)

  • 1. Detection of Brk expression in non-small cell lung cancer: clinicopathological relevance.
    Fan C; Zhao Y; Liu D; Zhang X; Wang E
    Tumour Biol; 2011 Oct; 32(5):873-80. PubMed ID: 21603980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer.
    Dai SD; Wang Y; Miao Y; Zhao Y; Zhang Y; Jiang GY; Zhang PX; Yang ZQ; Wang EH
    BMC Cancer; 2009 Jun; 9():178. PubMed ID: 19508730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance of lymphatic vessel density marked by D2-40 and E-cadherin expression in non-small-cell lung cancer.
    Jin S; Zhu W; Shi Q; Zhang Z; Guo R
    Med Oncol; 2012 Dec; 29(5):3157-61. PubMed ID: 22528515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological significance of cathepsin D expression in non-small cell lung cancer is conditional on apoptosis-associated protein phenotype: an immunohistochemistry study.
    Fan C; Lin X; Wang E
    Tumour Biol; 2012 Aug; 33(4):1045-52. PubMed ID: 22302483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PBK/TOPK expression in non-small-cell lung cancer: its correlation and prognostic significance with Ki67 and p53 expression.
    Lei B; Liu S; Qi W; Zhao Y; Li Y; Lin N; Xu X; Zhi C; Mei J; Yan Z; Wan L; Shen H
    Histopathology; 2013 Nov; 63(5):696-703. PubMed ID: 24025073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression and cytoplasmic accumulation of Hepl is associated with clinicopathological parameters and poor prognosis in non-small cell lung cancer.
    Miao Y; Wang L; Liu Y; Li AL; Liu SL; Cao HY; Zhang XP; Jiang GY; Liu D; Wang EH
    Tumour Biol; 2013 Feb; 34(1):107-14. PubMed ID: 23001926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. delta-Catenin promotes malignant phenotype of non-small cell lung cancer by non-competitive binding to E-cadherin with p120ctn in cytoplasm.
    Zhang JY; Wang Y; Zhang D; Yang ZQ; Dong XJ; Jiang GY; Zhang PX; Dai SD; Dong QZ; Han Y; Zhang S; Cui QZ; Wang EH
    J Pathol; 2010 Sep; 222(1):76-88. PubMed ID: 20593408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours.
    Vicent S; López-Picazo JM; Toledo G; Lozano MD; Torre W; Garcia-Corchón C; Quero C; Soria JC; Martín-Algarra S; Manzano RG; Montuenga LM
    Br J Cancer; 2004 Mar; 90(5):1047-52. PubMed ID: 14997206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-17F expression correlates with clinicopathologic factors and biological markers in non-small cell lung cancer.
    Li C; Ma X; Tan C; Fang H; Sun Y; Gai X
    Pathol Res Pract; 2019 Oct; 215(10):152562. PubMed ID: 31387805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
    Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
    Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of survivin and its clinical significance in non-small cell lung cancer].
    Ren YJ; Zhang QY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):504-7. PubMed ID: 16224523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a phosphorylated form of ATF4 in lung and non-small cell lung cancer tissues.
    Fan CF; Miao Y; Lin XY; Zhang D; Wang EH
    Tumour Biol; 2014 Jan; 35(1):765-71. PubMed ID: 23975372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of E-cadherin in lung carcinoma, other than those with small cells (NSCLC).
    Grigoraş ML; Arghirescu TS; Folescu R; Talpoş IC; Gîndac CM; Zamfir CL; Cornianu M; Anghel MD; Levai CM
    Rom J Morphol Embryol; 2017; 58(4):1317-1325. PubMed ID: 29556623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of NEDD9 is associated with altered expression of E-Cadherin, β-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer.
    Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Yang LH; Liu Y; Wang EH
    Pathol Oncol Res; 2013 Apr; 19(2):281-6. PubMed ID: 23086683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer.
    Tsubochi H; Sato N; Hiyama M; Kaimori M; Endo S; Sohara Y; Imai T
    Ann Thorac Surg; 2006 Oct; 82(4):1198-204. PubMed ID: 16996907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer.
    Liu J; Lin Y; Yang H; Deng Q; Chen G; He J
    Tumour Biol; 2011 Dec; 32(6):1113-21. PubMed ID: 21779982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.
    Goncharuk VN; del-Rosario A; Kren L; Anwar S; Sheehan CE; Carlson JA; Ross JS
    Ann Diagn Pathol; 2004 Feb; 8(1):6-16. PubMed ID: 15129904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p0071 interacts with E-cadherin in the cytoplasm so as to promote the invasion and metastasis of non-small cell lung cancer.
    Zhao H; Zhang D; Yang L; Wang E
    Mol Carcinog; 2018 Jan; 57(1):89-96. PubMed ID: 28898462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.